Page loading,Please wait...

Revising the Methodology of CNI Vaccine and Biotechnology Index

Time:2022-08-16

 In order to enhance the index investability, Shenzhen Securities Information Co., Ltd. decided to revise the methodology of CNI Vaccine and Biotechnology Index by revising the weighting method to "The weight of individual vaccine constituent is set no more than 15%, the weight of other individual constituent is set no more than 3%, the total weight of top 5 constituents does not exceed 60% and the total weight of constituents in vaccine industry is not less than 2/3 in each periodic review". The rest of the methodology remains the same.

The revision will be implemented on August 19, 2022. Please refer to the official website of CNI Index (www.cnindex.com.cn) for more details. 

 

Shenzhen Securities Information Co., Ltd.

 

 August 16, 2022